Your research cart is empty.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
High-purity, structurally verified peptide sequences for advanced laboratory and pre-clinical applications.
Cagrilintide is a long-acting amylin analog with a fatty acid side chain. With the molecular formula C₁₉₀H₂₉₇N₅₁O₅₈ and a molecular weight of 4220.8 g/mol (CAS: 1417329-69-3), it structurally mimics e...
Lab Verified
Clinical Grade
PMID Cited
Published preclinical research has characterized the following molecular pathways and receptor interactions for Cagrilintide.
Published research demonstrates Cagrilintide modulates targeted signaling cascades within cell tissue models (PMID: 41702251).
In cellular environments, Cagrilintide exhibits selective binding and corresponding pathway activation (PMID: 41109426).
Alhalabi et al. (2026) investigated Cagrilintide's binding affinity and receptor interactions in vitro (PMID: 41702251).
Briere et al. (2025) investigated Cagrilintide's binding affinity and receptor interactions in vitro (PMID: 41109426).
RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.
MetabolicC10H11N2 (free base) · 159.21 g/mol (free base)
For in vitro research use only. Not for human consumption.
MetabolicC9H14N4O5 · 258.23 g/mol
For in vitro research use only. Not for human consumption.
MetabolicC78H123N23O23S2 · 1815.12 g/mol
For in vitro research use only. Not for human consumption.